We next evaluated the effect of TPX2 lactylation on the in vivo HCC tumour growth by employing an HCC xenograft mouse model established via the subcutaneous injection of HepG2 cells with endogenous TPX2 knockdown and Flag-TPX2WT or Flag-TPX2K249R re-expression. Here, TPX2 is linked to hepatocellular carcinoma.